BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Acosta ML, Mat Nor MN, Guo CX, Mugisho OO, Coutinho FP, Rupenthal ID, Green CR. Connexin therapeutics: blocking connexin hemichannel pores is distinct from blocking pannexin channels or gap junctions. Neural Regen Res 2021;16:482-8. [PMID: 32985469 DOI: 10.4103/1673-5374.290097] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Y, Khan S, Liu Y, Siddique R, Zhang R, Yong VW, Xue M. Gap Junctions and Hemichannels Composed of Connexins and Pannexins Mediate the Secondary Brain Injury Following Intracerebral Hemorrhage. Biology (Basel) 2021;11:27. [PMID: 35053024 DOI: 10.3390/biology11010027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
2 King DR, Sedovy MW, Leng X, Xue J, Lamouille S, Koval M, Isakson BE, Johnstone SR. Mechanisms of Connexin Regulating Peptides. Int J Mol Sci 2021;22:10186. [PMID: 34638526 DOI: 10.3390/ijms221910186] [Reference Citation Analysis]
3 Laird DW, Lampe PD. Cellular mechanisms of connexin-based inherited diseases. Trends Cell Biol 2021:S0962-8924(21)00147-1. [PMID: 34429228 DOI: 10.1016/j.tcb.2021.07.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
4 Shome A, Mugisho OO, Niederer RL, Rupenthal ID. Blocking the inflammasome: A novel approach to treat uveitis. Drug Discov Today 2021:S1359-6446(21)00306-8. [PMID: 34229084 DOI: 10.1016/j.drudis.2021.06.017] [Reference Citation Analysis]
5 O'Shaughnessy EM, Duffy W, Garcia-Vega L, Hussey K, Burden AD, Zamiri M, Martin PE. Dysregulation of Connexin Expression Plays a Pivotal Role in Psoriasis. Int J Mol Sci 2021;22:6060. [PMID: 34199748 DOI: 10.3390/ijms22116060] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Sabirov RZ, Islam MR, Okada T, Merzlyak PG, Kurbannazarova RS, Tsiferova NA, Okada Y. The ATP-Releasing Maxi-Cl Channel: Its Identity, Molecular Partners and Physiological/Pathophysiological Implications. Life (Basel) 2021;11:509. [PMID: 34073084 DOI: 10.3390/life11060509] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Marsh SR, Williams ZJ, Pridham KJ, Gourdie RG. Peptidic Connexin43 Therapeutics in Cardiac Reparative Medicine. J Cardiovasc Dev Dis 2021;8:52. [PMID: 34063001 DOI: 10.3390/jcdd8050052] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
8 Potter JA, Price GW, Cliff CL, Green CR, Squires PE, Hills CE. Collagen I Modifies Connexin-43 Hemichannel Activity via Integrin α2β1 Binding in TGFβ1-Evoked Renal Tubular Epithelial Cells. Int J Mol Sci 2021;22:3644. [PMID: 33807408 DOI: 10.3390/ijms22073644] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Mat Nor MN, Rupenthal ID, Green CR, Acosta ML. Differential Action of Connexin Hemichannel and Pannexin Channel Therapeutics for Potential Treatment of Retinal Diseases. Int J Mol Sci 2021;22:1755. [PMID: 33578721 DOI: 10.3390/ijms22041755] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]